Lv41
638 积分 2024-04-02 加入
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
39分钟前
求助中
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
40分钟前
待确认
Acute graft-versus-host disease
1个月前
已完结
Two-Year Follow-up of Investigator-Initiated Phase 1 Trials of the Safety and Efficacy of Fully Human Anti-Bcma CAR T Cells (CT053) in Relapsed/Refractory Multiple Myeloma
3个月前
已完结
CAR‐T cell therapy targeting B cell maturation antigen is effective for relapsed/refractory multiple myeloma, including cases with poor performance status
4个月前
已完结
Opposing LSD1 complexes function in developmental gene activation and repression programmes
4个月前
已完结
Anti-GPRC5D CAR T-cell therapy as a salvage treatment in patients with progressive multiple myeloma after anti-BCMA CAR T-cell therapy: a single-centre, single-arm, phase 2 trial
5个月前
已完结
Clinical Applications of Exosomes: A Critical Review
8个月前
已完结
Clinical applications of stem cell-derived exosomes
8个月前
已完结
A review on exosomes application in clinical trials: perspective, questions, and challenges
8个月前
已完结
Acute myeloid leukaemia
1年前
已采纳
皖公网安备34019202002308
